Nosocomial Acinetobacter pneumonia
- PMID: 17986104
- DOI: 10.1111/j.1440-1843.2007.01147.x
Nosocomial Acinetobacter pneumonia
Abstract
Acinetobacter spp. (A. baumannii is the prevalent genomic species, but others may cause infection) has become an increasingly important cause of nosocomial pneumonia, particularly in mechanically ventilated patients (VAP). This organism has intrinsic resistance to some antimicrobials but easily acquires resistance to many others; Acinetobacter spp. can survive for long periods of time in the environment. All of these characteristics have contributed to protracted outbreaks associated with significant morbidity and mortality. High rates of colonization are found in debilitated hospitalized patients. Infecting or colonizing organisms in nosocomial infections are more likely to be from cross-transmission or from the hospital environment than from endogenous sources. VAP caused by Acinetobacter spp. is emerging as a prominent hospital complication. The incidence of this microorganism varies from site to site, but it is the second commonest aetiological agent among the gram-negative bacteria. Longer periods of hospitalization, longer time on mechanical ventilation and prior use of antibiotics are the recognized factors increasing the risk of VAP due to Acinetobacter spp. Treatment needs to clearly differentiate infection from colonization, and the agents with the most antimicrobial activity are imipenem/cilastatin, amikacin, colistin, ampicillin/sulbactam and tigecycline. Monotherapy can be adequate if the patient does not have significant comorbidities. Infection control procedures have a major role to play in preventing transmission of this microorganism. Emphasis on initial control measures should, however, be on strict isolation of infected or colonized patients to limit dissemination of outbreak strains in the environment. The variety of potential sources of contamination with Acinetobacter spp. in the hospital environment makes control of these outbreaks one of the more difficult challenges. Persistence of Acinetobacter spp. in the environment provides ample opportunities for contamination of patients and staff and may explain continuing long-term outbreaks.
Similar articles
-
[Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].Mikrobiyol Bul. 2009 Oct;43(4):575-85. Mikrobiyol Bul. 2009. PMID: 20084910 Turkish.
-
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.J Antimicrob Chemother. 2008 Sep;62 Suppl 1:i29-40. doi: 10.1093/jac/dkn249. J Antimicrob Chemother. 2008. PMID: 18684704 Clinical Trial.
-
Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.Ann Pharmacother. 2004 Sep;38(9):1449-59. doi: 10.1345/aph.1D592. Epub 2004 Jul 27. Ann Pharmacother. 2004. PMID: 15280512 Review.
-
[Nosocomial infection/colonization of the respiratory tract caused by Acinetobacter baumannii in an Internal Medicine ward].An Med Interna. 2002 Oct;19(10):511-4. An Med Interna. 2002. PMID: 12481493 Spanish.
-
The epidemiology and control of Acinetobacter baumannii in health care facilities.Clin Infect Dis. 2006 Mar 1;42(5):692-9. doi: 10.1086/500202. Epub 2006 Jan 26. Clin Infect Dis. 2006. PMID: 16447117 Review.
Cited by
-
Challenges Facing Two Outbreaks of Carbapenem-Resistant Acinetobacter baumannii: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants.Antibiotics (Basel). 2024 Aug 21;13(8):784. doi: 10.3390/antibiotics13080784. Antibiotics (Basel). 2024. PMID: 39200084 Free PMC article.
-
Multiple lung abscesses due to acinetobacter infection: a case report.Cases J. 2009 Dec 18;2:9347. doi: 10.1186/1757-1626-2-9347. Cases J. 2009. PMID: 20062600 Free PMC article.
-
Carbapenem resistance and Acinetobacter baumannii in Senegal: the paradigm of a common phenomenon in natural reservoirs.PLoS One. 2012;7(6):e39495. doi: 10.1371/journal.pone.0039495. Epub 2012 Jun 20. PLoS One. 2012. Retraction in: PLoS One. 2025 May 9;20(5):e0324349. doi: 10.1371/journal.pone.0324349. PMID: 22745768 Free PMC article. Retracted.
-
Mucin acts as a nutrient source and a signal for the differential expression of genes coding for cellular processes and virulence factors in Acinetobacter baumannii.PLoS One. 2018 Jan 8;13(1):e0190599. doi: 10.1371/journal.pone.0190599. eCollection 2018. PLoS One. 2018. PMID: 29309434 Free PMC article.
-
Prevalence of Pseudomonas aeruginosa and Acinetobacter spp. in subgingival biofilm and saliva of subjects with chronic periodontal infection.Braz J Microbiol. 2014 Aug 29;45(2):495-501. doi: 10.1590/s1517-83822014000200017. eCollection 2014. Braz J Microbiol. 2014. PMID: 25242933 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous